Medicine News and Research

RSS

MedPage and CollabRx introduce CancerRx to help oncologists, pathologists

MedPage Today, a property of Everyday Health, Inc. and CollabRx, Inc. announced today the introduction of a new physician resource, CancerRx,™ an IOS application designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options.

28 May 2014

Contemporary dataset reveals burden of paediatric pneumococcal disease

Children with chronic or immunocompromising medical conditions continue to be at increased risk for developing pneumococcal disease in the current era of universal immunisation, US researchers report.

28 May 2014

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).

28 May 2014

Princess Margaret signs MOU with Tata Memorial to pool cancer knowledge and expertise

Two world-renowned cancer centres today announced they will work together to further a shared vision of advancing innovation and delivery of best practices in all aspects of cancer care, research and education.

28 May 2014

Merck Serono launches web-based software system for MS patients receiving Rebif treatment

A new web and app-based software solution, launched in the UK today on World MS Day, will allow physicians and nurses to monitor treatment of patients taking MS disease-modifying treatment Rebif by collecting injection history through the new RebiSmart 2.0 electronic autoinjector.

28 May 2014

InControl Medical’s InToneMV gains FDA clearance for treatment of urinary, fecal incontinence in male

InControl Medical gains FDA clearance for InTone®MV providing the 12 million men nationally who suffer with urinary or fecal incontinence a non-surgical, implant-free solution

28 May 2014

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).

28 May 2014

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn’s disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.

28 May 2014

Critically ill patients receiving steroids in ICU are more likely to develop delirium

New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital’s intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.

28 May 2014

State regulators seek to impose controls on new painkiller

Several outlets look at prescription drug issues, including how to handle Zohydro -- a powerful painkiller approved by the FDA in March, and ethical questions raised by new "smart pills."

28 May 2014

Physical activity program reduces risk of major mobility disability among older adults

Among older adults at risk of disability, participation in a structured moderate-intensity physical activity program, compared with a health education intervention, significantly reduced the risk of major mobility disability (defined in this trial as loss of ability to walk 400 meters, or about a quarter mile), according to a study published by JAMA.

28 May 2014

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

A genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells, Johns Hopkins scientists report. Unlike many known disease-linked variants, this one lies not in a gene but in so-called noncoding DNA, a growing focus of disease research.

28 May 2014

Study detects hormone receptor's key role in normal organ development and function

A discovery by UC Irvine endocrinologists about the importance of cell surface receptors for estrogen has the potential to change how researchers view the hormone's role in normal organ development and function.

28 May 2014

Study reveals loss of function of gene RARRES3 in breast cancer cells promotes metastasis to lung

A study published today in EMBO Molecular Medicine reveals that the loss of function of the gene RARRES3 in breast cancer cells promotes metastasis to the lung.

28 May 2014

Neural engineers to develop techniques for dynamic deep brain stimulation

Deep brain stimulators, devices that zap Parkinson's disease tremors by sending electrical current deep into nerve centers near the brain stem, may sound like they are cutting-edge, but Rice University's Caleb Kemere wants to give them a high-tech overhaul.

28 May 2014

Patients receiving steroids in hospital's ICU more likely to develop delirium, says study

New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital's intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.

28 May 2014

Case Western Reserve physician calls on FDA to address hidden risk of dangerous drugs side effects

The agency charged to protect patients from dangerous drug side effects needs to be far more vigilant when it comes to medications that affect blood pressure.

28 May 2014

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

A drug's half-life indicates how long a substance will remain active in the body. It is essentially the period of time that it takes for the concentration of the amount of the drug to be reduced by half, and therefore, determines how frequently a drug needs to be administered to maintain its therapeutic effect.

27 May 2014

Imperial College London receives £40 million gift for new biomedical engineering centre

Imperial College London is to build a new and pioneering biomedical engineering centre thanks to an unprecedented £40 million gift from Michael Uren OBE and the Michael Uren Foundation.

27 May 2014

Griffith, Blackmores Institute launch special online course on complementary medicines

Pharmacists and other healthcare professionals will have the opportunity to boost their knowledge of complementary medicines when Griffith University and Blackmores Institute launch a special online course.

27 May 2014

Medicine News and Research

MedPage and CollabRx introduce CancerRx to help oncologists, pathologists

Contemporary dataset reveals burden of paediatric pneumococcal disease

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Princess Margaret signs MOU with Tata Memorial to pool cancer knowledge and expertise

Merck Serono launches web-based software system for MS patients receiving Rebif treatment

InControl Medical’s InToneMV gains FDA clearance for treatment of urinary, fecal incontinence in male

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

Critically ill patients receiving steroids in ICU are more likely to develop delirium

State regulators seek to impose controls on new painkiller

Physical activity program reduces risk of major mobility disability among older adults

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

Study detects hormone receptor's key role in normal organ development and function

Study reveals loss of function of gene RARRES3 in breast cancer cells promotes metastasis to lung

Neural engineers to develop techniques for dynamic deep brain stimulation

Patients receiving steroids in hospital's ICU more likely to develop delirium, says study

Case Western Reserve physician calls on FDA to address hidden risk of dangerous drugs side effects

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

Imperial College London receives £40 million gift for new biomedical engineering centre

Griffith, Blackmores Institute launch special online course on complementary medicines

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News